Mauna Kea Technologies announces that the transfer of its ordinary shares from the regulated market of Euronext Paris (Compartment C) to the multilateral trading facility Euronext Growth Paris will take effect on August 8.

The application to list the shares on Euronext Growth Paris, the project for which was authorized by the AGM of shareholders held on June 2, was approved by the Euronext Admissions Committee at its meeting on August 3.

This transfer should simplify the medical technology company's operations and reduce the costs associated with its listing, while enabling it to continue to benefit from the attractions of the financial markets.

Copyright (c) 2023 CercleFinance.com. All rights reserved.